HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barry Rosenbloom Selected Research

imiglucerase

12/2020Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease.
9/2017Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
1/2017Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy.
6/2015Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.
5/2014A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability.
8/2012Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barry Rosenbloom Research Topics

Disease

8Gaucher Disease (Gaucher's Disease)
12/2020 - 08/2012
2Thrombocytopenia (Thrombopenia)
08/2012 - 02/2003
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2020
1Myocardial Infarction
06/2015
1Psychotic Disorders (Schizoaffective Disorder)
06/2015
1Splenomegaly
08/2012
1Hepatomegaly
08/2012
1Body Weight (Weight, Body)
04/2010
1Anaphylaxis (Anaphylactic Shock)
04/2010
1Urticaria (Hives)
04/2010
1Vomiting
04/2010
1Glycogen Storage Disease Type II (Pompe's Disease)
04/2010
1Flushing
04/2010
1Hyperhidrosis
04/2010
1Muscular Diseases (Myopathy)
04/2010
1Crohn Disease (Crohn's Disease)
02/2003

Drug/Important Bio-Agent (IBA)

6imigluceraseFDA Link
12/2020 - 08/2012
4eliglustatIBA
01/2019 - 06/2015
2Rituximab (Mabthera)FDA Link
12/2020 - 02/2003
2Monoclonal AntibodiesIBA
12/2020 - 02/2003
2EnzymesIBA
12/2020 - 04/2010
1Vincristine (Oncovin)FDA LinkGeneric
12/2020
1Prednisone (Sone)FDA LinkGeneric
12/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020
1algluceraseFDA Link
09/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1alpha-Glucosidases (Acid Maltase)IBA
04/2010
1human GAA protein (Myozyme)FDA Link
04/2010
1Pharmaceutical PreparationsIBA
04/2010
1GlycogenIBA
04/2010
1AcidsIBA
04/2010

Therapy/Procedure

5Enzyme Replacement Therapy
12/2020 - 05/2014
3Therapeutics
01/2019 - 08/2012
2Enzyme Therapy
01/2017 - 08/2012
1Stem Cell Transplantation
12/2020
1Aftercare (After-Treatment)
08/2012